Peripheral Blood Eosinophil and Neutrophil Biomarkers for Discriminating Acute Exacerbations of COPD: A Retrospective Comparative Study
This retrospective study of 421 COPD patients found that while acute exacerbations are associated with a distinct low-eosinophil/high-neutrophil pattern, peripheral blood eosinophil and neutrophil counts, as well as their ratios, demonstrated only modest discriminatory accuracy and are insufficient as standalone diagnostic indicators.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Chronic obstructive pulmonary disease, or COPD, is a long-term condition that makes breathing difficult by narrowing the airways and damaging the lungs. For people living with this disease, the most dangerous moments are often not the steady days of breathlessness, but the sudden spikes in symptoms known as acute exacerbations. During these episodes, a patient's breathing worsens rapidly, often triggered by infections or pollution, leading to emergency room visits and hospital stays. To understand what is happening inside the body during these crises, doctors look at the blood. Two specific types of white blood cells are particularly important here: neutrophils, which are the body's rapid-response soldiers that rush to fight off infections, and eosinophils, which are involved in allergic reactions and a different kind of inflammation. In stable periods, the balance between these cells can vary from person to person, but during a severe attack, the body's immune response shifts dramatically, and researchers have long wondered if measuring these shifts could help doctors quickly identify who is sick and how sick they are.
A team of researchers in Turkey decided to investigate whether simple blood tests could distinguish between COPD patients who were having a sudden attack and those who were stable. They looked back at the medical records of 701 patients who had been followed for COPD over the course of a year. After removing records that were incomplete or belonged to patients who had recently taken steroids or visited the emergency room for other reasons, they were left with 421 people to study. The group was split into two: 253 patients who were currently experiencing an acute exacerbation and 168 patients who were not. The researchers examined the blood samples taken from these patients right when they arrived at the hospital, before any new treatment was given, to see if the numbers of neutrophils and eosinophils, or the ratio between them, could tell the difference between a stable patient and one in crisis.
The results showed a clear pattern in the blood of those having an attack. The patients in the exacerbation group had significantly fewer eosinophils and significantly more neutrophils compared to the stable group. When the researchers calculated the ratio of eosinophils to neutrophils, the number was much lower in the sick group, while the reverse ratio of neutrophils to eosinophils was much higher. This suggests that during a severe COPD flare-up, the body shifts toward a state dominated by neutrophils, the infection-fighting cells, while the eosinophils drop away. The researchers also noticed that this shift was even more extreme in patients who were sick enough to be admitted to the hospital compared to those who were treated as outpatients. Those who were hospitalized had the lowest eosinophil counts and the highest neutrophil counts, hinting that the severity of the blood cell imbalance might mirror the severity of the illness.
Despite these clear differences, the study found that these blood markers were not perfect tools for diagnosis on their own. The researchers used a statistical method to see how well each marker could predict whether a patient was having an attack. The best performer was the absolute count of neutrophils, which correctly identified the situation about two-thirds of the time. The other markers, including the ratios between the cells, performed slightly worse. While the differences between the groups were statistically real, the ability of any single blood test to act as a standalone diagnostic tool was modest. In other words, while the blood of a patient having an attack looks different from the blood of a stable patient, a doctor cannot rely on just one of these numbers to make a definitive call without looking at the patient's symptoms and history.
The study also explored whether these blood changes could help predict who would need to be hospitalized. The data confirmed that patients with the most extreme shifts—very low eosinophils and very high neutrophils—were indeed the ones most likely to be admitted. However, the authors caution that this pattern might be a reaction to the stress of the infection or the body's own natural production of stress hormones, rather than the direct cause of the attack. Because the study was a look back at past records, it could not prove cause and effect, nor could it determine if these blood tests would predict a future attack before it happened. The researchers concluded that while these readily available blood indices provide a useful snapshot of the body's inflammatory balance during a crisis, they should be used to support a doctor's clinical judgment rather than replace it. To truly know if these markers can guide treatment or predict future risks, larger and more detailed studies are needed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.